Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Jan-Feb;19(1):1-7.
doi: 10.1016/j.bjid.2014.07.003. Epub 2014 Sep 16.

Factors associated with inspiratory muscle weakness in patients with HIV-1

Fabiana S Jerônimo  1 , Giovanni N Alves  2 , Gerson Cipriano Jr  3 , Paulo J C Vieira  4 , Adriana M Güntzel Chiappa  4 , Gaspar R Chiappa  5
Affiliations
Comparative Study

Factors associated with inspiratory muscle weakness in patients with HIV-1

Fabiana S Jerônimo et al. Braz J Infect Dis. 2015 Jan-Feb.

Abstract

Background: the impact of human immunodeficiency virus type 1 (HIV-1) on lung function is well known and associated with a reduction in pulmonary ventilation. Moreover, the use of highly active antiretroviral therapy has been associated with mitochondrial dysfunction and decreased muscle strength. However, there is scarce information about the factors associated with inspiratory muscle weakness in these patients.

Objective: the purpose of the present study was to investigate the factors associated with inspiratory muscle weakness in patients with HIV-1.

Methods: two-hundred fifty seven patients with HIV-1 were screened and categorized into two groups: (1) IMW+ (n=142) and (2) IMW- (n=115). Lung function (FEV1, FVC and FEV1/FVC), maximum inspiratory pressure, distance on the six-minute walk test and CD4 cell count were assessed.

Results: the mean duration of HIV infection was similar in the two groups. The following variables were significantly different between groups: mean duration of highly active antiretroviral therapy (81±12 in IMW+ versus 38±13 months in IMW-; p=0.01), and CD4 cell count (327±88 in IMW+ versus 637±97cells/mm(3) in IMW-; p=0.02). IMW+ presented reduced lung function (FEV1, FVC, FEV1/FVC).

Conclusion: patients with IMW+ had lower distance on the six-minute walk test in comparison to the IMW- group. The duration of highly active antiretroviral therapy, distance traveled on the 6MWT and CD4 count were determinants of IMW in patients with HIV.

Keywords: Diaphragm muscle; Exercise tolerance, highly active antiretroviral therapy; Inflammatory response; Inspiratory muscle; Lung function.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The CONSORT-flow diagram of patients in the study.
Fig. 2
Fig. 2
Scattergram of the association between maximum inspiratory pressure (MIP) and CD4 count (cells/mm3) for all subjects. Open circles represent patients without inspiratory muscle weakness. Filled circles represent patients with inspiratory muscle weakness. r = Pearson's correlation coefficient.
See this image and copyright information in PMC

References

    1. Marins J.R., Jamal L.F., Chen S.Y., et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17:1675–1682. - PubMed
    1. Lazzaretti R.K., Kuhmmer R., Sprinz E., et al. Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial. J Am Coll Cardiol. 2012;59:979–988. - PubMed
    1. Sterne J.A., Hernan M.A., Ledergerber B., et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366:378–384. - PubMed
    1. Degano B., Guillaume M., Savale L., et al. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS. 2010;24:67–75. - PubMed
    1. Oursler K.K., Katzel L.I., Smith B.A., et al. Prediction of cardiorespiratory fitness in older men infected with the human immunodeficiency virus: clinical factors and value of the six-minute walk distance. J Am Geriatr Soc. 2009;57:2055–2061. - PMC - PubMed

Publication types

Substances